December 5th, 2011

Healthy Minds: Unlocking the Secrets of the Brain


From Husseini K. Manji, M.D., Global Therapeutic Area Head for Neuroscience, Janssen Research & Development, LLC.

We’re on the cusp of a golden age for neuroscience. We’re probing deeper into the intricacies of the brain and beginning to see novel ideas translate into better lives for millions of people.

But to discover the next revolutionary idea, we need to come together as a field – government, academia and industry – and share knowledge, buy cheap cialis super force online data, tools and models to enhance our understanding of disease biology, identify new treatment targets, develop new diagnostics and improve outcomes for patients with disease.

I’ve been involved in neuroscience research for more than 18 years, first at the National Institutes of Health and now at J&J, and I have experienced firsthand the decline in federal and industry support and the fragmentation of research between industry and academia, both of which have slowed the pace of progress. Order eriacta in our online pharmacy without a prescription The science continues to be complicated and difficult, and navigating the road to solutions will require greater collaboration and cooperation. What is clear is that no single entity can get to the next great breakthrough working alone.

Read More

December 1st, 2011

World AIDS Day, 2011: Our Commitment to Prevention, Detection, Education and Treatment


December 1st is World AIDS Day. With 2011 marking  30 years since the Centers for Disease Control made the first mention of the disease  that would come to be known HIV, this anniversary is especially poignant. Johnson & Johnson and our Family of Companies remain committed to the prevention, detection, education and treatment of HIV/AIDS, and I wanted to share with you some of those ongoing efforts.

In our commitment to HIV prevention, care and support, Johnson & Johnson’s Corporate Contributions group partners with organizations working both globally and locally in over 100 programs.  For example:

•    Employing HIV-positive mothers to mentor newly-diagnosed HIV-positive pregnant women in South Africa.
•    Enhancing the leadership and management skills of domestic AIDS Service Organizations to improve service delivery.
•    Teaching kids in Zimbabwe about HIV prevention through fun and engaging soccer drills. Linking HIV-positive individuals to care in China.
•    Using village savings and loan groups in Malawi as a forum to teach men and women about HIV/AIDS and health.
•    Supporting orphans and vulnerable children infected and affected by HIV/AIDS in communities around the world.

These are just a few of the innovative and meaningful domestic and global programs that Johnson & Johnson supports.

Read More

November 29th, 2011

7 Summits for Alzheimer’s Awareness

From Ellen Rose, Director, Communications and Public Affairs, Janssen Alzheimer Immunotherapy

November is National Caregivers Month in the United States and also National Alzheimer’s Awareness Month.  According to Alzheimer’s Disease International, as many as 36 million people worldwide are living with dementia and that number is expected to double every 20 years. The worldwide cost of dementia amounts to more than 1 percent of global GDP or $604 billion US dollars and in the United States, an estimated 10.9 million unpaid caregivers see to the daily needs of people with Alzheimer’s.

These are staggering numbers that are hard to put into perspective, but sometimes the societal and human impact of this devastating and fatal disease is better put into context through the personal experience of someone with a family member who suffers from Alzheimer’s.

I am privileged to work with one such individual – Alan Arnette, an Alzheimer’s disease advocate who has combined his passion for mountain climbing with advocacy through the 7 Summits Climb for Alzheimer’s:  Memories are Everything.  The 7 Summits is a public awareness campaign that that shines a light on the need for more research, education and urgency to address Alzheimer’s (Janssen Alzheimer Immunotherapy is a sponsor of this campaign). 

Read More

November 23rd, 2011

Johnson & Johnson and Social Health at BlogWorld

From Devon Eyer, Director, Social Media, Johnson & Johnson

For the second consecutive year, Johnson & Johnson was the primary sponsor for the Social Health track at BlogWorld and New Media Expo, held November 3-5, 2011 in Los Angeles.  The event, which attracts attendees interested in emerging trends in social media and digital technology, has been a rich and rewarding opportunity for us to connect with patients, physicians, nurses, caregivers, advocates and digital health organizations looking to find information, share ideas, and most importantly – connect with others who want to affect change in healthcare.

As the newest member of the Johnson & Johnson Corporate Social Media team, I had the pleasure of attending this year’s event and found it to be a great introduction to what’s going on in the space.  I came away inspired by the passion and depth of speakers and attendees, and impressed by the lively and interactive discussions about challenges, successes and best practices from patients, practitioners and advocates for use of social media to advance healthcare.  Conversations ranged from privacy and rules of the road, to brainstorms about authenticity and making sure relevant, credible information rises to the top of searches for patients who need it. 

Read More

November 22nd, 2011

Addressing the Challenges of HIV Drug Supply

From Will Stephens, Vice President, Global Access & Partnerships, Janssen Global Services, LLC

Recently, I attended the Clinton Health Access Initiative’s (CHAI) 2nd Antiretroviral (ARV) Supplier Summit in Kerala, India. Over the course of three days, CHAI brought together innovator pharmaceutical companies and generic drug manufacturers as well as civil society representatives to explore the trends and challenges of broadening HIV drug delivery.

A key theme of the summit was sustainability and suppliers’ capacity to meet the rapidly growing needs for HIV drugs. In 2005, 1.3 million people with HIV were receiving ARV treatment in low and middle-income countries; in 2009, 5.2 million were on treatment. By 2015, an estimated 15 million people will be targeted for ARV treatment.

As we heard throughout the summit, this is a challenging time for those of us working to broaden access to these medicines in resource-limited settings. The demand for safe and effective HIV drugs is increasing, while funding for HIV programs is flat or decreasing. Companies – both innovator and generic – are under constant pressure to produce safer, more effective, more convenient HIV medicines ever more cheaply.

It was clear from summit discussions that having more generic companies manufacturing HIV drugs may not always expand access and/or lower prices; and in fact, it’s likely to drive high quality, higher-priced generic manufacturers out of the market.

Read More

November 21st, 2011

National Psoriasis Awareness Campaign, Are You Serious?, Launches New Online Community

From Craig Stoltz, Director, Product Communication, Immunology, Janssen Biotech, Inc.

Last November, I posted about the launch of a national awareness campaign for people living with plaque psoriasis, called Are You Serious?TM, which you may remember featured renowned comedian Jon Lovitz. Inspired by finding a treatment that worked for him after living with psoriasis for nearly a decade, Lovitz told his psoriasis story and infused his unique style of humor into Are You Serious?TM to illustrate the everyday impact of this disease, while reinforcing the importance of having open and frank discussions with a dermatologist. 

A year later, my colleagues and I are still working on raising awareness for people with plaque psoriasis, which is the most prevalent autoimmune disease in the United States.  This year, we are shifting the Are You Serious?TM spotlight to the millions of Americans living with plaque psoriasis  — so they can share the moments that motivated them to get serious about psoriasis. Buy Kamagra Oral Jelly online 100mg Sildenafil Citrate We hope that this expansion of the conversation will give people an outlet to talk about what led them to work with a dermatologist towards effectively managing their symptoms, and will motivate others to do the same. 

Read More

November 11th, 2011

A Veteran’s Day Reflection on Mental Health

From Bill Weldon, Chairman and Chief Executive Officer, Johnson & Johnson

Each Veterans Day, Americans take a collective pause to express our gratitude for those who so honorably serve in the Armed Forces. We say a silent thank you for all who sacrificed their lives in the cause of freedom, and applaud the heroism and bravery of returning veterans whose visible wounds often bear witness to their time on the front lines. But this Veterans Day, many of our young men and women in uniform are struggling with less visible wounds: traumatic injuries that don’t require a prosthetic or wheelchair – yet leave deep and lasting scars on the mind.

The challenge of treating and curing diseases and injuries to the brain is more critical than ever.  After nine years of frequent deployments, today’s combat veterans are increasingly suffering not only traumatic brain injuries but also the emotional and psychological wounds of Post Traumatic Stress Disorder (PTSD) and other mental conditions including addiction, depression and suicide. A 2011 study of returning soldiers conducted by the National Institute on Drug Abuse found that one in five active duty and more than four in ten reserve soldiers had been diagnosed as needing mental health treatment.

Read More

November 10th, 2011

Remembering Our Veterans

From Russell Clayton, Sourcing Manager—PLDP, Johnson & Johnson World Headquarters, Co-Chair, Veterans Leadership Council

Veterans Day holds a special place in my heart. For nine years, I served as a Captain in the United States Army, Corps of Engineers and participated in Operation Iraqi Freedom in 2003.The diverse experiences I’ve had in the military have played a tremendous role in my life both personally and professionally. In the military, Order Cheapest Kamagra soft 100mg Without Prescription Sildenafil Citrate I learned not only about the value of discipline and teamwork in reaching a common goal, but also how to lead others. Today, as the co-chair of the Veterans Leadership Council (VLC), one of our affinity groups here at Johnson & Johnson, I can also say with great pride that Johnson & Johnson has a long legacy of serving and empowering its many employees who have served, and continue to serve in the military.

Johnson & Johnson employees volunteering through military service is a tradition that began in 1898 with the Spanish American War when two employees in the U.S. volunteered to serve in the military. One of those employees had just been hired at the Company, but felt it was his patriotic duty to serve his country, which the Company supported fully–even paying the employee’s salary while he served (today the Company pays the difference between the J&J and military salary).

Read More

November 10th, 2011

Health and Economic Growth at APEC

From Clifford Holland, Corporate Vice President, Government Affairs and Public Policy, Johnson & Johnson

Today I begin my first day at the 2011 Asia Pacific Economic Cooperation (APEC) CEO Summit, which brings together more than 1,500 business and government leaders from the 21 APEC member economies.  The purpose of the summit is to facilitate economic cooperation and the development of frameworks for trade, investment and regulatory policy in the region. In this global economic climate, there is a sense of urgency as leaders from the APEC countries convene to discuss prospects for recovery and long-term sustainable economic growth. Collaboration among the APEC economies is vital to creating the business environments that fuel growth and innovation. I know that at Johnson & Johnson we share the concerns of these leaders, and look forward to working together to seek solutions.

This week’s meetings will, of course, focus on policies more conducive to business investment, such as those that reduce barriers to trade and level the competitive playing field. However, it is important to note that development in the APEC economies is also tightly linked to the state of a nation’s health, or more specifically, its people’s health

Restoring and sustaining growth requires policies that recognize the role of health care as the largest sector of the global – and APEC – economies, and a prime driver of growth.

Read More

November 9th, 2011

Shedding Light on Driving in the Dark

From Gary Esterow, Senior Director, Public Relations, VISTAKON® Division of Johnson & Johnson Vision Care, Inc.

On November 6, we turned our clocks back an hour in the United States. For those of us who drive, the end of Daylight Savings Time means more time driving in the dark.

We may not be conscious of it, but when we are behind the wheel, our eyes are constantly on the move – looking at cars ahead and to the side, reading traffic signs, and checking the rearview mirror.  Then our eyes shift to objects a bit closer such as the speedometer, global navigation system and the radio. When it’s dark, these tasks can become much more difficult for some drivers.

As I’ve gotten older, I’ve noticed little changes when I am driving in low-light conditions.  I notice that glare from headlights seems to bother me a bit more and I just get this feeling that my vision could be a bit sharper. I recently went for my annual eye exam and discussed this with my optometrist. A comprehensive eye exam confirmed that my eyes were healthy.  After he checked my vision, we agreed to try a slight change in my contact lens prescription to improve my distance vision.

Read More